These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36420069)

  • 1. Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An
    Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH
    Oncol Lett; 2022 Dec; 24(6):448. PubMed ID: 36420069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition.
    Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH; Jang HJ
    Mol Biol Rep; 2021 Sep; 48(9):6231-6240. PubMed ID: 34392440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway.
    Bhat FA; Sharmila G; Balakrishnan S; Arunkumar R; Elumalai P; Suganya S; Raja Singh P; Srinivasan N; Arunakaran J
    J Nutr Biochem; 2014 Nov; 25(11):1132-1139. PubMed ID: 25150162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3.
    Liao CH; Liu Y; Wu YF; Zhu SW; Cai RY; Zhou L; Yin XM
    J Cell Physiol; 2019 Aug; 234(10):17786-17799. PubMed ID: 30887508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Napsin A resensitizes drug-resistant lung cancer A549 cells to gefitinib by inhibiting EMT.
    Zhou L; Lv X; Yang J; Zhu Y; Wang Z; Xu T
    Oncol Lett; 2018 Aug; 16(2):2533-2538. PubMed ID: 30008942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragalus polysaccharides reverse gefitinib resistance by inhibiting mesenchymal transformation in lung adenocarcinoma cells.
    Wei J; Li Y; Xu B; Yu J
    Am J Transl Res; 2020; 12(5):1640-1657. PubMed ID: 32509166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.
    Xue L; Su D; Li D; Gao W; Yuan R; Pang W
    Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
    Lim WC; Kim H; Ko H
    J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway.
    Zhou P; Wang C; Hu Z; Chen W; Qi W; Li A
    BMC Cancer; 2017 Dec; 17(1):813. PubMed ID: 29202800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI.
    Weng CH; Chen LY; Lin YC; Shih JY; Lin YC; Tseng RY; Chiu AC; Yeh YH; Liu C; Lin YT; Fang JM; Chen CC
    Oncogene; 2019 Jan; 38(4):455-468. PubMed ID: 30111817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ROS/Akt/NF-κB Signaling Cascade Mediates Epidermal Growth Factor-Induced Epithelial-Mesenchymal Transition and Invasion in Human Breast Cancer Cells.
    Min WL; Wang BF; Liang BB; Zhang L; Pan JY; Huang Y; Zhao Y; Lin S; Zhao YH; Zhang SQ; Ma QY
    World J Oncol; 2022 Oct; 13(5):289-298. PubMed ID: 36406192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid suppresses epithelial-mesenchymal transition and cancer stem cell formation by reducing the levels of peroxiredoxin II and reactive oxygen species in pancreatic cancer cells.
    Kim YJ; Jeong SH; Kim EK; Kim EJ; Cho JH
    Oncol Rep; 2017 Dec; 38(6):3632-3638. PubMed ID: 29130098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
    Zhao YL; Yuan BQ; Shen GS
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?
    Cheng JC; Auersperg N; Leung PC
    PLoS One; 2012; 7(3):e34071. PubMed ID: 22479527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting c-kit inhibits gefitinib resistant NSCLC cell growth and invasion through attenuations of stemness, EMT and acquired resistance.
    Zhou Y; Wang L; Sun Z; Zhang J; Wang X
    Am J Cancer Res; 2020; 10(12):4251-4265. PubMed ID: 33414998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.